Latest RTW INVESTMENTS, LP Stock Portfolio
RTW INVESTMENTS, LP Performance:
2024 Q3: 2.36%YTD: 9.57%2023: 4.11%
Performance for 2024 Q3 is 2.36%, and YTD is 9.57%, and 2023 is 4.11%.
About RTW INVESTMENTS, LP and 13F Hedge Fund Stock Holdings
RTW INVESTMENTS, LP is a hedge fund based in NEW YORK, NY. On 30-May-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $7.2 Billions. In it's latest 13F Holdings report, RTW INVESTMENTS, LP reported an equity portfolio of $6.9 Billions as of 30 Sep, 2024.
The top stock holdings of RTW INVESTMENTS, LP are MDGL, AXSM, RNA. The fund has invested 6.1% of it's portfolio in MADRIGAL PHARMACEUTICALS INC and 5.4% of portfolio in AXSOME THERAPEUTICS INC.
The fund managers got completely rid off INTUITIVE SURGICAL INC (ISRG), VERICEL CORP (VCEL) and FULCRUM THERAPEUTICS INC (FULC) stocks. They significantly reduced their stock positions in ULTRAGENYX PHARMACEUTICAL IN (RARE), TAYSHA GENE THERAPIES INC (TSHA) and SAB BIOTHERAPEUTICS INC (SABS). RTW INVESTMENTS, LP opened new stock positions in GERON CORP (GERN), STRYKER CORPORATION (SYK) and ORUKA THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS INC (CGEM), ORCHESTRA BIOMED HLDGS INC and ESSA PHARMA INC (EPIX).
The top stock holdings of RTW INVESTMENTS, LP are MDGL, AXSM, RNA. The fund has invested 6.1% of it's portfolio in MADRIGAL PHARMACEUTICALS INC and 5.4% of portfolio in AXSOME THERAPEUTICS INC.
The fund managers got completely rid off INTUITIVE SURGICAL INC (ISRG), VERICEL CORP (VCEL) and FULCRUM THERAPEUTICS INC (FULC) stocks. They significantly reduced their stock positions in ULTRAGENYX PHARMACEUTICAL IN (RARE), TAYSHA GENE THERAPIES INC (TSHA) and SAB BIOTHERAPEUTICS INC (SABS). RTW INVESTMENTS, LP opened new stock positions in GERON CORP (GERN), STRYKER CORPORATION (SYK) and ORUKA THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to CULLINAN THERAPEUTICS INC (CGEM), ORCHESTRA BIOMED HLDGS INC and ESSA PHARMA INC (EPIX).
RTW INVESTMENTS, LP Annual Return Estimates Vs S&P 500
Our best estimate is that RTW INVESTMENTS, LP made a return of 2.36% in the last quarter. In trailing 12 months, it's portfolio return was 32.86%.
New Buys
| Ticker | $ Bought |
|---|---|
| geron corp | 200,268,000 |
| stryker corporation | 143,392,000 |
| oruka therapeutics inc | 45,359,400 |
| bioage labs inc | 16,356,100 |
| xencor inc | 11,563,200 |
| wave life sciences ltd | 7,380,000 |
| ideaya biosciences inc | 6,336,000 |
| artiva biotherapeutics inc | 2,299,640 |
New stocks bought by RTW INVESTMENTS, LP
Additions
| Ticker | % Inc. |
|---|---|
| cullinan therapeutics inc | 62.07 |
| orchestra biomed hldgs inc | 46.00 |
| essa pharma inc | 41.89 |
| stoke therapeutics inc | 10.12 |
| akero therapeutics inc | 8.97 |
| penumbra inc | 7.23 |
| dyne therapeutics inc | 6.76 |
| urogen pharma ltd | 6.47 |
Additions to existing portfolio by RTW INVESTMENTS, LP
Reductions
| Ticker | % Reduced |
|---|---|
| ultragenyx pharmaceutical in | -39.63 |
| taysha gene therapies inc | -20.5 |
| sab biotherapeutics inc | -17.17 |
| insmed inc | -10.11 |
| axsome therapeutics inc | -9.6 |
| avidity biosciences inc | -7.65 |
| arvinas inc | -6.25 |
| alkermes plc | -5.71 |
RTW INVESTMENTS, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| fulcrum therapeutics inc | -36,244,900 |
| kyverna therapeutics inc | -13,895,300 |
| cutera inc | -2,010,980 |
| cytomx therapeutics inc | -1,464,000 |
| adicet bio inc | -1,274,960 |
| vericel corp | -36,768,100 |
| viridian therapeutics inc | -7,881,670 |
| sagimet biosciences inc | -1,710,000 |
RTW INVESTMENTS, LP got rid off the above stocks
Sector Distribution
RTW INVESTMENTS, LP has about 85.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.1 |
| Others | 14.9 |
Market Cap. Distribution
RTW INVESTMENTS, LP has about 10.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 54.9 |
| SMALL-CAP | 17.1 |
| UNALLOCATED | 17.1 |
| LARGE-CAP | 10.3 |
Stocks belong to which Index?
About 60.6% of the stocks held by RTW INVESTMENTS, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 58.5 |
| Others | 39.5 |
| S&P 500 | 2.1 |
RTW INVESTMENTS, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of RTW INVESTMENTS, LP
RTW INVESTMENTS, LP has 68 stocks in it's portfolio. About 46.1% of the portfolio is in top 10 stocks. MDGL proved to be the most loss making stock for the portfolio. PTGX was the most profitable stock for RTW INVESTMENTS, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABIO | arca biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACAD | acadia pharmaceuticals inc | 3.05 | 13,707,500 | 210,821,000 | unchanged | 0.00 | ||
| ACET | adicet bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 1.39 | 3,258,360 | 95,828,400 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 2.46 | 5,919,440 | 169,829,000 | added | 8.97 | ||
| ALKS | alkermes plc | 2.69 | 6,654,030 | 186,246,000 | reduced | -5.71 | ||
| ARVN | arvinas inc | 0.99 | 2,782,330 | 68,528,800 | reduced | -6.25 | ||
| ARYD | arya sciences acqu corp iv | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 5.45 | 4,189,560 | 376,515,000 | reduced | -9.6 | ||
| BRKR | bruker corp | 3.48 | 3,481,120 | 240,406,000 | added | 1.07 | ||
| CGEM | cullinan therapeutics inc | 0.41 | 1,705,960 | 28,557,800 | added | 62.07 | ||
| CNTA | centessa pharmaceuticals plc | 0.01 | 50,000 | 799,500 | new | |||
| CTMX | cytomx therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CUTR | cutera inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 2.08 | 2,721,160 | 143,677,000 | unchanged | 0.00 | ||
| DYN | dyne therapeutics inc | 3.54 | 6,818,640 | 244,926,000 | added | 6.76 | ||
| EPIX | essa pharma inc | 0.29 | 3,261,500 | 19,764,700 | added | 41.89 | ||
| ESTA | establishment labs hldgs inc | 1.66 | 2,645,700 | 114,480,000 | reduced | -1.12 | ||
| ETNB | 89bio inc | 0.79 | 7,378,550 | 54,601,300 | unchanged | 0.00 | ||
| FULC | fulcrum therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||